General Information of Drug (ID: DMC812I)

Drug Name
US9434727, 153 Drug Info
Synonyms SCHEMBL17223023; CHEMBL3892497; BDBM249555; US9434727, 153
Cross-matching ID
PubChem CID
118483501
TTD Drug ID
DMC812I

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tinlarebant DM6JYUO Stargardt disease 9B70 Phase 3 [2]
A1-10436 DM9ESPR N. A. N. A. Patented [3]
US9434727, 93 DMCJG8Z N. A. N. A. Patented [4]
US9434727, 40 DMLPWK3 N. A. N. A. Patented [5]
US8586571, 12 DMKLJ6O N. A. N. A. Patented [6]
A1-10438 DMJD1S6 N. A. N. A. Patented [3]
US8586571, 36 DMX3A0O N. A. N. A. Patented [6]
US8853215, 3 DMX8NLB N. A. N. A. Patented [3]
US8586571, 6 DM1N74R N. A. N. A. Patented [6]
US9434727, 120 DMIT0H3 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasma retinol-binding protein (RBP4) TT0C8BY RET4_HUMAN Inhibitor [1]

References

1 Substituted 4-phenylpiperidines, their preparation and use. US9434727.
2 Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development. Eur J Med Chem. 2021 Dec 15;226:113856.
3 Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215.
4 Substituted 4-phenylpiperidines, their preparation and use. US10072016.
5 Substituted 4-phenylpiperidines, their preparation and use. US9777010.
6 Heterocyclic compound. US8586571.